請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/44820完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 陳秀熙(Tony Hsiu-Hsi Chen) | |
| dc.contributor.author | Chung-Hsien Chaou | en |
| dc.contributor.author | 趙從賢 | zh_TW |
| dc.date.accessioned | 2021-06-15T03:55:41Z | - |
| dc.date.available | 2011-10-16 | |
| dc.date.copyright | 2011-10-03 | |
| dc.date.issued | 2011 | |
| dc.date.submitted | 2011-08-17 | |
| dc.identifier.citation | 1. Jeyaratnam, J. and J. Jeyaratnam, Acute pesticide poisoning: a major global health problem. World Health Statistics Quarterly - Rapport Trimestriel de Statistiques Sanitaires Mondiales, 1990. 43(3): p. 139-44.
2. Eddleston, M., Patterns and problems of deliberate self-poisoning in the developing world. Qjm, 2000. 93(11): p. 715-31. 3. Yang, C.C., et al., Taiwan National Poison Center: epidemiologic data 1985-1993. Journal of Toxicology - Clinical Toxicology, 1996. 34(6): p. 651-63. 4. Lin, T.-J., 台灣有機磷農藥急性中毒個案分析. 2006國際化災應變暨中毒急救研討會, 2006. 5. Lee, P., et al., Clinical features of patients with acute organophosphate poisoning requiring intensive care. Intensive Care Medicine, 2001. 27(4): p. 694-9. 6. Sungur, M. and M. Guven, Intensive care management of organophosphate insecticide poisoning. Crit Care, 2001. 5(4): p. 211-5. 7. Grmec, S., S. Mally, and P. Klemen, Glasgow Coma Scale score and QTc interval in the prognosis of organophosphate poisoning. Acad Emerg Med, 2004. 11(9): p. 925-30. 8. Tsao, T.C., et al., Respiratory failure of acute organophosphate and carbamate poisoning. Chest, 1990. 98(3): p. 631-6. 9. World Health Organization. Environmental Health Criteria No 63. Organophosphorus Pesticides: A General Introduction. World Health Organization, G., World Health Organization, Geneva 1986. 1986. 10. World Health Organization. Environmental Health Criteria No 63. Organophosphorus Pesticides: A General Introduction. World Health Organization, G., . World Health Organization, Geneva, 1989; updated 1999. Available online at: http://www.inchem.org/documents/pims/chemical/pimg001.htm 1999. 11. Buckley, N.A., M. Eddleston, and L. Szinicz, Oximes for acute organophosphate pesticide poisoning [Systematic Review]. Cochrane Database of Systematic Reviews, 2006(2). 12. Peter, J.V., et al., Oxime therapy and outcomes in human organophosphate poisoning: an evaluation using meta-analytic techniques.[see comment]. Critical Care Medicine, 2006. 34(2): p. 502-10. 13. Pawar, K.S., et al., Continuous pralidoxime infusion versus repeated bolus injection to treat organophosphorus pesticide poisoning: a randomised controlled trial.[see comment]. Lancet, 2006. 368(9553): p. 2136-41. 14. Eddleston, M., et al., Pralidoxime in acute organophosphorus insecticide poisoning--a randomised controlled trial. PLoS Med, 2009. 6(6): p. e1000104. 15. Sam, K.G., et al., Poisoning severity score, APACHE II and GCS: effective clinical indices for estimating severity and predicting outcome of acute organophosphorus and carbamate poisoning. J Forensic Leg Med, 2009. 16(5): p. 239-47. 16. Bilgin, T.E., et al., The comparison of the efficacy of scoring systems in organophosphate poisoning. Toxicology & Industrial Health, 2005. 21(7-8): p. 141-6. 17. Eizadi-Mood, N., M. Saghaei, and M. Jabalameli, Predicting outcomes in organophosphate poisoning based on APACHE II and modified APACHE II scores. Human & Experimental Toxicology, 2007. 26(7): p. 573-8. 18. Davies, J.O., M. Eddleston, and N.A. Buckley, Predicting outcome in acute organophosphorus poisoning with a poison severity score or the Glasgow coma scale. Qjm, 2008. 101(5): p. 371-9. 19. Sungurtekin, H., et al., Evaluation of several clinical scoring tools in organophosphate poisoned patients. Clinical Toxicology: The Official Journal of the American Academy of Clinical Toxicology & European Association of Poisons Centres & Clinical Toxicologists, 2006. 44(2): p. 121-6. 20. Knaus, W.A., et al., APACHE II: a severity of disease classification system. Critical Care Medicine, 1985. 13(10): p. 818-29. 21. Worek, F., et al., Diagnostic aspects of organophosphate poisoning. Toxicology, 2005. 214(3): p. 182-9. 22. Thiermann, H., et al., Red blood cell acetylcholinesterase and plasma butyrylcholinesterase status: important indicators for the treatment of patients poisoned by organophosphorus compounds. Arh Hig Rada Toksikol, 2007. 58(3): p. 359-66. 23. Thiermann, H., et al., Correlation between red blood cell acetylcholinesterase activity and neuromuscular transmission in organophosphate poisoning. Chem Biol Interact, 2005. 157-158: p. 345-7. 24. Cardon, N., et al., [Acute organophosphorus pesticide poisoning and cholinesterases activities]. Ann Biol Clin (Paris), 2005. 63(3): p. 329-34. 25. Nouira, S., et al., Prognostic value of serum cholinesterase in organophosphate poisoning. Chest, 1994. 106(6): p. 1811-4. 26. Aygun, D., et al., Serum acetylcholinesterase and prognosis of acute organophosphate poisoning. J Toxicol Clin Toxicol, 2002. 40(7): p. 903-10. 27. Chen, H.Y., et al., Prognostic value of serial serum cholinesterase activities in organophosphate poisoned patients. Am J Emerg Med, 2009. 27(9): p. 1034-9. 28. Fitzmaurice, G.M., N.M. Laird, and J.H. Ware, Applied Longitudinal Analysis. Hoboken, NJ: John Wiley & Sons Inc. 2004. 29. Brown, H. and R. Prescott, Applied Mixed Models in Medicine. 2nd ed. Chichester, UK: John Wiley & Sons Ltd. 2006. 30. SAS Institude Inc., SAS 9.2 Documentation. 2011; Available from: http://support.sas.com. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/44820 | - |
| dc.description.abstract | 簡介 — 有機磷在世界各地廣泛地被使用於農業及環境衛生上,而中毒事件也層出不窮。其主要機轉為身體膽鹼酯酶受有機磷抑制導致乙醯膽鹼過度刺激結後神經元或器官受器產生如腺體分泌物增加、肌肉無力、甚至昏迷等種種症狀。有機磷中毒病患血清膽鹼酯酶(SChE)在中毒後隨時間的變化相當程度代表了病患復元的情況,但每位病人的SChE具重覆測量的特性,相同病人檢驗值間將會出現相關性問題。線性混合模型為醫學上常用來處理重覆測量資料的方法之一,最主要是在模型中加入隨機效應來克服組內資料之間的相關性,並由隨機誤差中加以分離。本研究主旨為利用統計混合模型來探討有機磷中毒病患血清膽鹼酯酶(SChE)的恢復情形。
方法 —本研究之假說為有機磷中毒病患血清膽鹼酯酶與時間呈某種程度的相關性;不同病人血清膽鹼酯酶的初值與上升速度存在著個體差異;以及部份相關臨床因子會對膽鹼酯酶上升趨勢有影響。利用回溯性研究設計,收集自2000年至2010年因急性有機磷中毒至某醫學中心急診就診之成人病患共212位,由排除條件刪除81位餘下131位病患相關資料及共859筆SChE濃度資料。並收集病患個人基本資料、第一次生命徵象及嚴重度評估、各項檢查檢驗數據、中毒相關因素、接受的治療、各次SChE檢驗時間與結果、及預後等變項作分析。統計方法使用混合模型中的隨機係數模型,加入個人隨機截距效應及時間的隨機斜率,再放入臨床相關因子,並與一般線性回歸模型作比較。 結果 —有機磷中毒病患不論中毒物質種類、過去病史、就醫時間、症狀等等均存在很大的差異性,但多數病人的初次SChE濃度均有明顯的降低。SChE的分析呈現右偏分佈,經過對數轉換後(LSChE)分佈趨於對稱。LSChE的相關性矩陣顯示出各次測量值間確有正相關,且相關性由相鄰測量開始依測量間隔時間增加而逐漸遞減。混合模型的模型配適度顯著地較固定效應模型改善許多,可見中毒病患的嚴重度及復原過程的確存在很大的個人差異。混合模型配適的結果顯示病人LSChE濃度高低與時間、有機磷種類、初次測量值有關,而其隨著時間上升的斜率則與有機磷種類、初次測量值、及疾病嚴重度有關。在有機磷種類方面怖飛松(profenophos)有較低的SChE濃度、陶斯松(chlorpyrifos)的SChE上升趨勢較緩慢、達馬松(methamidophos)則上升趨勢較快。疾病嚴重程度較高、初次測量值較高的病患有較平緩的上升趨勢。性別、前24小時解毒劑2-PAM使用劑量、延遲就醫時間、與時間二次方均與上升趨勢相關性不顯著。 結論 — 本論文探討了有機磷中毒病患血清膽鹼酯酶濃度在復元過程的上升趨勢,研究結果可作為未來建構有機磷中毒病患復元模式的基礎。 | zh_TW |
| dc.description.abstract | Introduction—Organophosphate poisoning (OPP) occurs worldwide, accounting for 200,000 deaths annually in developing countries. Organophosphorus compounds inhibit the activity of cholinesterase and result in the over-activation of acetylcholine on autonomic ganglia and end organs. Serum cholinesterase (SChE) is of diagnostic value in OPP patients and often checked repeatedly during the treatment course. Most of the previous studies on OPP patients focused on mortality and disease severity, while the recovery pattern of SChE has been rarely addressed. To deal with the repeated measured SChE, correlation within the same patient must be taken into account. The linear mixed model is one of the most commonly used methods in repeated measures of normal data. It adds random effects in order to capture variance resulting from between-cluster level as well as intra-cluster correlation. This study aimed to investigate the dynamic relationship between SChE and time in OPP patients using linear mixed models.
Material and Methods—This study is a retrospective cohort study, utilizing medical records from a medical center in Taoyuan, Taiwan. A total of 212 adult patients who visited the emergency room between 2000 and 2010 due to acute OPP were included, and 131 patients were analyzed after exclusion of 81 patients by criteria. Information regarding basic personal characteristics, first vital signs and severity scores, lab data, type and ingestion amount of organophosphate, treatment, and serial SChE value were collected. Random coefficient model with random intercept and random slope of time were added to address the dynamic relationships of SChE with time and associated factors. Results—Organophosphate-poisoned patients differ significantly in baseline characteristics, but most patients had lowered initial SChE levels. The histogram of SChE revealed a positively skewed distribution and thus log-transformed SChE (LSChE) was used as the dependent variable. Serial LSChE showed a positive correlation with decreasing magnitude as the time gap increased. The goodness of fit significantly improved after random intercepts and random slopes of time were added to a linear mixed model. Time, type of organophosphate, and first LSChE level were independently related with LSChE level, while type of organophosphate, first LSChE level, and disease severity score were significantly related with the slope of time. Profenophos has lowest LSChE levels among all types of organophosphate. Chlorpyrifos and methamidophos had significant slower and faster rates of LSChE recovery compared with other organophosphates, respectively. Sex, dose of 2-PAM during the initial 24 hours, delay of medical assistance, and quadratic form of time did not significantly affect the recovery of LSChE. Conclusion—This study constructed a model for recovery of SChE in OPP patients. Several major determinants responsible for the recovery of SChE were also identified. It can be used as a prototype model in further studies on OPP. Clinicians may also make use of such information to guide clinical decisions during initial period of treatment. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-15T03:55:41Z (GMT). No. of bitstreams: 1 ntu-100-P98842001-1.pdf: 923498 bytes, checksum: 8b0f81515442b239bd794f0f20e4a77b (MD5) Previous issue date: 2011 | en |
| dc.description.tableofcontents | 中文摘要 i
Abstract iii 目錄 v Chapter 1 研究簡介與動機 1 Chapter 2 醫學文獻回顧 2 2.1 有機磷中毒之流行病學概況 2 2.2 有機磷中毒之毒理學 2 2.3 有機磷中毒的治療 3 2.4 有機磷中毒病患的的嚴重度評估 4 2.5 膽鹼酯酶在診斷及預後上的價值 4 Chapter 3 統計文獻回顧 6 3.1 重覆測量及其於醫學上的應用 6 3.2 線性混合模型 8 3.2.1 隨機截距模型 9 3.2.2 隨機係數模型 10 3.3 模型配適方法 11 Chapter 4 研究材料及方法 12 4.1 研究設計及環境 12 4.2 研究假說 12 4.3 病患納入及排除原則 12 4.4 收案與排除過程 13 4.5 收集變項 13 4.6 資料結構 15 4.7 統計方法 16 Chapter 5 研究結果 17 5.1 基本資料 17 5.2 依變數的分析 17 5.2.1 依變數的分配與對數轉換 17 5.2.2 依變數的相關性分析 18 5.3 模型配適結果 19 5.4 混合模型結果 20 Chapter 6 討論 21 6.1 研究主要發現 21 6.2 膽鹼酯酶濃度上升的影響因子討論 21 6.3 研究結果的臨床應用 22 6.4 未來研究方向 22 Chapter 7 研究限制 23 Chapter 8 結論 24 圖目錄 25 圖一 有機磷中毒機轉 26 圖二 收案及排除過程 27 圖三 有機磷種類統計圖 28 圖四 中毒個案年份統計 29 圖五 到院時間統計圖 30 圖六 臨床症狀出現占全部病人比例統計圖 31 圖七 病人起初神智狀況統計圖 32 圖八 APACHE II Score 統計圖 33 圖九 測量次數統計圖 34 圖十 血清膽鹼酯酶與時間(中毒後小時數)散佈圖 35 圖十一 個人SChE相對時間(中毒後小時數)上升趨勢線圖 36 圖十二 血清膽鹼酯酶(SChE)分佈圖 37 圖十三 個人LSChE與時間(中毒後小時數)散佈圖 38 圖十四 個人LSChE對時間(中毒後小時數)上升趨勢線圖 39 圖十五 血清膽鹼酯酶對數轉換後(LSChE)分佈圖 40 圖十六 存活及死亡病患的LSChE 分佈圖 41 圖十七 多次測量間的correlation scatter plot matrix 42 表目錄 43 表一 有機磷中毒症狀 44 表二 Glasgow Coma Scale 45 表三 原始資料結構 46 表四 轉置後的資料結構 47 表五 病患基本資料(類別變項) 48 表六 連續變項敘述性統計 49 表七 依變數(LSChE)各次測量平均值、標準差及樣本數 50 表八 LSChE各次測量彼此相關性矩陣 51 表九 模型內容總整理 52 表十 簡單線性迴歸模型結果整理 53 表十一 固定效應模型結果整理 54 表十二 混合模型結果整理 55 表十三 模型八有機磷種類相關參數估計 56 參考資料 57 附錄一 APACHE* II Score20 60 | |
| dc.language.iso | zh-TW | |
| dc.subject | 隨機效應 | zh_TW |
| dc.subject | 有機磷中毒 | zh_TW |
| dc.subject | 血清膽鹼酯酶 | zh_TW |
| dc.subject | 混合模型 | zh_TW |
| dc.subject | Mixed Models | en |
| dc.subject | Random Effects | en |
| dc.subject | Serum Cholinesterase | en |
| dc.subject | Organophosphate Poisoning | en |
| dc.title | 以線性混合模型探討有機磷中毒病人血清膽鹼酯酶與時間之動態關係 | zh_TW |
| dc.title | Dynamic Relationship Between Time and Serum Cholinesterase in Organophosphate-Poisoned Patients with Linear Mixed Model | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 99-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.coadvisor | 戴政(John Jen Tai) | |
| dc.contributor.oralexamcommittee | 張淑惠(Shu-Hui Chang) | |
| dc.subject.keyword | 有機磷中毒,血清膽鹼酯酶,混合模型,隨機效應, | zh_TW |
| dc.subject.keyword | Organophosphate Poisoning,Serum Cholinesterase,Mixed Models,Random Effects, | en |
| dc.relation.page | 61 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2011-08-18 | |
| dc.contributor.author-college | 公共衛生學院 | zh_TW |
| dc.contributor.author-dept | 流行病學與預防醫學研究所 | zh_TW |
| 顯示於系所單位: | 流行病學與預防醫學研究所 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-100-1.pdf 未授權公開取用 | 901.85 kB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
